文献
J-GLOBAL ID:202002273173136201
整理番号:20A2117441
高悪性度の漿液性卵巣癌に関する予後徴候遺伝子発現シグネチャー
Prognostic gene expression signature for high-grade serous ovarian cancer
著者 (120件):
MILLSTEIN J.
(Univ. Southern California, Los Angeles, USA)
,
BUDDEN T.
(Univ. NSW Sydney, Sydney, AUS)
,
BUDDEN T.
(Univ. Manchester, Manchester, GBR)
,
GOODE E. L.
(Mayo Clinic, Rochester, USA)
,
ANGLESIO M. S.
(Univ. British Columbia, Vancouver)
,
ANGLESIO M. S.
(Univ. British Columbia, Vancouver, CAN)
,
TALHOUK A.
(Univ. British Columbia, Vancouver)
,
TALHOUK A.
(Univ. British Columbia, Vancouver, CAN)
,
INTERMAGGIO M. P.
(Univ. NSW Sydney, Sydney, AUS)
,
LEONG H. S.
(Peter MacCallum Cancer Center, Melbourne, AUS)
,
CHEN S.
(Cedars-Sinai Medical Center, Los Angeles)
,
ELATRE W.
(Univ. Southern California, USA)
,
GILKS B.
(Univ. British Columbia, Vancouver)
,
NAZERAN T.
(Univ. British Columbia, Vancouver)
,
VOLCHEK M.
(Royal Women’s Hospital, Parkville, AUS)
,
BENTLEY R. C.
(Duke Univ. Hospital, Durham)
,
WANG C.
(Mayo Clinic, Rochester, USA)
,
CHIU D. S.
(Univ. British Columbia, Vancouver)
,
KOMMOSS S.
(Tuebingen Univ. Hospital, Tuebingen, DEU)
,
LEUNG S. C. Y.
(Univ. British Columbia, Vancouver)
,
SENZ J.
(Univ. British Columbia, Vancouver)
,
LUM A.
(Univ. British Columbia, Vancouver)
,
CHOW V.
(Univ. British Columbia, Vancouver)
,
SUDDERUDDIN H.
(Univ. British Columbia, Vancouver)
,
MACKENZIE R.
(Univ. British Columbia, Vancouver)
,
GEORGE J.
(Jackson Lab. for Genomic Medicine, Farmington, USA)
,
GROUP AOCS
(Peter MacCallum Cancer Center, Melbourne, AUS)
,
GROUP AOCS
(QIMR Berghofer Medical Res. Inst., Queensland)
,
GROUP AOCS
(Univ. Sydney, Sydney)
,
FEREDAY S.
(Peter MacCallum Cancer Center, Melbourne, AUS)
,
FEREDAY S.
(Univ. Melbourne, Parkville, AUS)
,
HENDLEY J.
(Peter MacCallum Cancer Center, Melbourne, AUS)
,
HENDLEY J.
(Univ. Melbourne, Parkville, AUS)
,
TRAFICANTE N.
(Peter MacCallum Cancer Center, Melbourne, AUS)
,
TRAFICANTE N.
(Univ. Melbourne, Parkville, AUS)
,
STEED H.
(Royal Alexandra Hospital, Edmonton)
,
KOZIAK J. M.
(Alberta Health Serv.-Cancer Care, Calgary)
,
KOEBEL M.
(Univ. Calgary, Calgary, CAN)
,
MCNEISH I. A.
(Imperial Coll. London, London)
,
MCNEISH I. A.
(Univ. Glasgow, Glasgow)
,
GORANOVA T.
(Univ. Cambridge, Cambridge, GBR)
,
ENNIS D.
(Imperial Coll. London, London)
,
ENNIS D.
(Univ. Glasgow, Glasgow)
,
MACINTYRE G.
(Univ. Cambridge, Cambridge, GBR)
,
DE SILVA D. Silva
(Univ. Cambridge, Cambridge, GBR)
,
CAJAL T. Ramon y
(Hospital Sant Pau, Barcelona)
,
GARCIA-DONAS J.
(HM Hospitales D Centro Integral Oncologico HM Clara Campal, Madrid)
,
POLO S. Hernando
(Hospital Universitario Funcacion Alcorcon, Alcorcon, ESP)
,
RODRIGUEZ G. C.
(Univ. Chicago, Evanston)
,
CUSHING-HAUGEN K. L.
(Fred Hutchinson Cancer Res. Center, Seattle)
,
HARRIS H. R.
(Fred Hutchinson Cancer Res. Center, Seattle)
,
HARRIS H. R.
(Univ. Washington, Seattle)
,
GREENE C. S.
(Univ. Pennsylvania, Philadelphia)
,
ZELAYA R. A.
(Geisel School of Medicine at Dartmouth, Hanover, USA)
,
BEHRENS S.
(German Cancer Res. Center (DKFZ), Heidelberg)
,
FORTNER R. T.
(German Cancer Res. Center (DKFZ), Heidelberg)
,
SINN P.
(Univ. Hospital Heidelberg, Heidelberg)
,
HERPEL E.
(Univ. Hospital Heidelberg, Heidelberg)
,
HERPEL E.
(Univ. Hospital and German Cancer Res. Center, Heidelberg, DEU)
,
LESTER J.
(Univ. California at Los Angeles, Los Angeles)
,
LESTER J.
(Cedars-Sinai Medical Center, Los Angeles)
,
LUBINSKI J.
(Pomeranian Medical Univ., Szczecin)
,
OSZUREK O.
(Pomeranian Medical Univ., Szczecin)
,
TOLOCZKO A.
(Pomeranian Medical Univ., Szczecin)
,
CYBULSKI C.
(Pomeranian Medical Univ., Szczecin)
,
MENKISZAK J.
(Pomeranian Medical Univ., Szczecin, POL)
,
PEARCE C. L.
(Univ. Michigan School of Public Health, Ann Arbor)
,
PEARCE C. L.
(Univ. Southern California Norris Comprehensive Cancer Center, Los Angeles)
,
PIKE M. C.
(Univ. Southern California Norris Comprehensive Cancer Center, Los Angeles)
,
PIKE M. C.
(Memorial Sloan-Kettering Cancer Center, New York)
,
TSENG C.
(Univ. Southern California, Los Angeles, USA)
,
ALSOP J.
(Univ. Cambridge, Cambridge)
,
RHENIUS V.
(Univ. Cambridge, Cambridge)
,
SONG H.
(Univ. Cambridge, Cambridge)
,
JIMENEZ-LINAN M.
(Addenbrooke’s Hospital NHS Trust, Cambridge)
,
PISKORZ A. M.
(Univ. Cambridge, Cambridge, GBR)
,
GENTRY-MAHARAJ A.
(Univ. Coll. London, London)
,
KARPINSKYJ C.
(Univ. Coll. London, London)
,
WIDSCHWENDTER M.
(Univ. Coll. London, London)
,
SINGH N.
(Barts Health National Health Serv. Trust, London, GBR)
,
KENNEDY C. J.
(Univ. Sydney, Sydney)
,
KENNEDY C. J.
(Westmead Hospital, Sydney)
,
SHARMA R.
(Univ. Sydney, Sydney)
,
SHARMA R.
(Univ. Western Sydney at Westmead Hospital, Sydney)
,
HARNETT P. R.
(Univ. Sydney, Sydney)
,
HARNETT P. R.
(Westmead Hospital, Sydney, AUS)
,
GAO B.
(Univ. Sydney, Sydney)
,
GAO B.
(Westmead Hospital, Sydney, AUS)
,
JOHNATTY S. E.
(QIMR Berghofer Medical Res. Inst., Queensland)
,
SAYER R.
(Westmead Hospital, Sydney)
,
BOROS J.
(Univ. Sydney, Sydney)
,
BOROS J.
(Westmead Hospital, Sydney)
,
WINHAM S. J.
(Mayo Clinic, Rochester, USA)
,
KEENEY G. L.
(Mayo Clinic, Rochester)
,
KAUFMANN S. H.
(Mayo Clinic, Rochester)
,
LARSON M. C.
(Mayo Clinic, Rochester, USA)
,
LUK H.
(Univ. Hawaii Cancer Center, Honolulu)
,
HERNANDEZ B. Y.
(Univ. Hawaii Cancer Center, Honolulu)
,
THOMPSON P. J.
(Cedars-Sinai Medical Center, Los Angeles)
,
WILKENS L. R.
(Univ. Hawaii Cancer Center, Honolulu)
,
CARNEY M. E.
(Univ. Hawaii, Honolulu)
,
TRABERT B.
(NationalCancer Inst., Bethesda, USA)
,
LISSOWSKA J.
(M Sklodowska Curie National Res. Inst. of Oncology, Warsaw, POL)
,
BRINTON L.
(NationalCancer Inst., Bethesda, USA)
,
SHERMAN M. E.
(Mayo Clinic Coll. of Medicine, Jacksonville, USA)
,
BODELON C.
(NationalCancer Inst., Bethesda, USA)
,
HINSLEY S.
(Univ. Glasgow, Glasgow)
,
LEWSLEY L. A.
(Univ. Glasgow, Glasgow)
,
GLASSPOOL R.
(Univ. Glasgow, Glasgow)
,
BANERJEE S. N.
(Royal Marsden NHS Foundation Trust and Inst. of Cancer Res., London, GBR)
,
STRONACH E. A.
(Imperial Coll. London, London)
,
HALUSKA P.
(Mayo Clinic, Rochester)
,
RAY-COQUARD I.
(Univ. Claude Bernard Lyon 1, Lyon, FRA)
,
MAHNER S.
(LMU Munich, Munich, DEU)
,
WINTERHOFF B.
(Univ. Minnesota, Minneapolis)
,
SLAMON D.
(Univ. California at Los Angeles, Los Angeles)
,
LEVINE D. A.
(Memorial Sloan-Kettering Cancer Center, New York)
,
LEVINE D. A.
(NYU Langone Medical Center, New York)
,
KELEMEN L. E.
(Medical Univ. of South Carolina, Charleston, USA)
,
BENITEZ J.
(Centro de Investigacion en Red de Enfermedades Raras (CIBERER), Madrid)
資料名:
Annals of Oncology
(Annals of Oncology)
巻:
31
号:
9
ページ:
1240-1250
発行年:
2020年09月
JST資料番号:
W0107A
ISSN:
0923-7534
CODEN:
ANONE2
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
イギリス (GBR)
言語:
英語 (EN)